4-Chromanone
ISO
491-37-2
Huateng Pharma
Per request
2023-03-17
PEG derivatives & pharmaceutical intermediates
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
Chromanone
Other Name:4H-1-Benzopyran-4-one,2,3-dihydro-;4-Chromanone;2,3-Dihydro-4H-1-benzopyran-4-one;Chromanone;2,3-Dihydro-4-benzopyranone;2,3-Dihydro-4H-chromen-4-one;NSC 174058;2,3-Dihydrochromen-4-one;Dihydrobenzopyran-4-one;3,4-Dihydro-2H-1-benzopyran-4-one
CAS No.:491-37-2
Molecular Formula:C9H8O2
InChIKeys:InChIKey=MSTDXOZUKAQDRL-UHFFFAOYSA-N
Molecular Weight:148.16
Exact Mass:148.16
BRN:124652
EC Number:207-736-3
NSC Number:174058
DSSTox ID:DTXSID3060081
HScode:2932999099
Categories:
Characteristics-
PSA:
26.3
XLogP3:1.4
Appearance:White to yellow Crystalline Powder, Crystals or Low Melting Mass
Density:1.1291 g/cm3 @ Temp: 99.8 °C
Melting Point:36.5 °C
Boiling Point:160 °C @ Press: 50 Torr
Flash Point:>230 °F
Refractive Index:n20/D 1.575(lit.)
Water Solubility:Slightly soluble in water.
Storage Conditions:0-10°C
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
PEG derivatives & pharmaceutical intermediates
-
Location:
Hunan Huateng Pharmaceutical Co., Ltd
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
35
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
301-500
-
Year of Establishment:
2013
-
Certifications:
ISO9001
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product